Nonsyndromic hearing loss is a conductive or sensorineural hearing loss that occurs without associated systemic pathologies or hereditary syndromes. This condition can vary in severity and often affects the patient's quality of life, limiting their social interactions and emotional state. Nonsyndromic hearing loss can manifest itself in varying degrees - from mild hearing loss to complete deafness, and affect one or both ears. The causes that contribute to the development of this pathology include both genetic factors and external influences, including injuries, infections, and exposure to noise.
History of the disease and interesting historical facts
Nonsyndromic hearing loss has been defined for centuries. Its origins can be traced back to ancient times, when doctors attempted to explain the lack of sound perception using theories related to the dysfunction of the ears. Historical records exist that mention various methods of hearing compensation, ranging from the use of auditory tubes to the first prostheses. The 20th century saw a quantum leap in understanding the mechanics of hearing, thanks to research in the field of audiology and the advent of new technologies such as hearing aids and implants. These advances have played a major role in improving the lives of people suffering from nonsyndromic hearing loss.
Epidemiology
According to the World Health Organization, non-syndromic hearing loss affects about 466 million people worldwide, which is about 5% of the population. About 34 million of them are children. The risk of developing this pathology increases with age, and by the age of 60, about 25% people have some degree of hearing loss. In the older age group, starting from 65 years, this figure can reach 40-50%. Various studies confirm that in developing countries, the prevalence of non-syndromic hearing loss may be significantly higher, due to limited access to health care and a high incidence of ear infections.
Genetic predisposition to this disease
Several genes have already been identified as potential sources of non-syndromic hearing loss. Among them are:
- GJB2 (connexin 26) is the most common gene associated with susceptibility to non-syndromic hearing loss;
- SLC26A4 – can cause both syndromic and non-syndromic hearing loss;
- MYO15A – associated with sensorineural hearing loss;
- OTOF is a gene involved in the transmission of sound impulses in the auditory analyzer.
Mutations in these genes can lead to a predisposition to hearing loss, even in the absence of other pathologies.
Risk factors for the development of this disease
Various factors may contribute to the risk of developing nonsyndromic hearing loss, including:
- Age – the risk increases with age;
- Genetic predisposition – a family history of hearing loss;
- Noise trauma is prolonged or intense exposure to high-volume sound waves;
- Diseases such as meningitis, otitis, scarlet fever;
- Exposure to toxic substances - such as lead, solvents;
- Taking certain medications – aminoglycosides, aspirin in large doses.
By studying risk factors, we can better understand the mechanisms by which non-syndromic hearing loss occurs and possibly prevent its development.
Diagnosis of this disease
Diagnosis of non-syndromic hearing loss is based on a comprehensive approach and includes:
- The main symptoms are difficulty in perceiving speech, especially in noisy environments, and a feeling of blocked ears;
- Laboratory tests – genetic testing for mutations in audiogenic genes;
- Radiological examinations – CT or MRI of the head to exclude anatomical abnormalities;
- Other types of diagnostics – audiometry, otoacoustic emission;
- Differential diagnosis – exclusion of syndromic forms of hearing loss and other ear diseases.
This approach allows for an accurate diagnosis and the development of an effective treatment plan.
Treatment
Treatment for nonsyndromic hearing loss depends on its cause and severity. It may include:
- General treatment – lifestyle changes, restrictions on impact on hearing;
- Pharmacological treatment – the use of drugs to improve the blood supply to the inner ear;
- Surgical treatment – in case of obstruction of the auditory canal or structural abnormalities;
- Other types of treatment include the use of hearing aids and cochlear implants.
Therapy can be individualized depending on the specifics of the case and the patient's preferences.
List of medications used to treat this disease
Some of the medications used to treat nonsyndromic hearing loss include:
- Vasoactive agents - eg pentoxifylline;
- Antioxidant drugs – such as n-acetylcysteine;
- Glucocorticosteroids – for inflammatory processes, for example, prednisolone;
- Preparations for improving blood microcirculation – Trental.
The choice of medications is made by the doctor, taking into account the clinical situation.
Disease monitoring
Monitoring of non-syndromic hearing loss should include regular audiometric testing.
- Control stages – mandatory examinations by an otolaryngologist and a hearing specialist;
- Prognosis – with timely diagnosis and adequate treatment, the prognosis is usually favorable;
- Complications – complications associated with delayed diagnosis and treatment may include progression of hearing loss and social isolation.
This approach allows us to provide the best results for patients.
Age-related features of the disease
Non-syndromic hearing loss has different manifestations depending on age:
- In children, congenital hearing loss is most common, requiring early diagnosis and intervention;
- In adolescents, it may occur as a result of exposure to noise or infectious diseases;
- In adults, age-related hearing loss is most common, requiring special hearing aids;
- In older people, it is complicated by concomitant diseases such as diabetes and hypertension.
Understanding age-related aspects is key to treating and supporting patients.
Questions and Answers
- What is nonsyndromic hearing loss? It is a hearing loss that is not accompanied by other systemic diseases and can vary in severity from mild hearing loss to complete deafness.
- Who is at risk for nonsyndromic hearing loss? Older people, people with a genetic predisposition, and those exposed to noise and toxic substances.
- How is non-syndromic hearing loss diagnosed? Diagnosis includes examination, audiometry, genetic testing and, if necessary, radiological methods.
- What are the treatments for non-syndromic hearing loss? Treatment may include medication, surgery, and the use of hearing aids.
- What is the prognosis for patients with non-syndromic hearing loss? The prognosis depends on the cause and when treatment is started, but with timely diagnosis and treatment the results are usually favorable.
